Compare IMVT & CENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IMVT | CENX |
|---|---|---|
| Founded | 2018 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Aluminum |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 6.1B |
| IPO Year | 2019 | 2004 |
| Metric | IMVT | CENX |
|---|---|---|
| Price | $28.29 | $60.66 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 3 |
| Target Price | $31.22 | ★ $65.67 |
| AVG Volume (30 Days) | 1.4M | ★ 1.9M |
| Earning Date | 05-28-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.42 |
| Revenue | N/A | ★ $1,893,200,000.00 |
| Revenue This Year | N/A | $20.77 |
| Revenue Next Year | N/A | $14.58 |
| P/E Ratio | ★ N/A | $142.10 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $13.36 | $14.77 |
| 52 Week High | $30.09 | $68.69 |
| Indicator | IMVT | CENX |
|---|---|---|
| Relative Strength Index (RSI) | 59.48 | 51.51 |
| Support Level | $22.25 | $57.48 |
| Resistance Level | $29.25 | $68.69 |
| Average True Range (ATR) | 1.24 | 3.21 |
| MACD | 0.36 | -0.81 |
| Stochastic Oscillator | 72.73 | 29.92 |
Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The company operates in a single operating segment, which includes all activities related to the research, development and manufacturing of its product candidates.
Century Aluminum Co produces primary aluminum standard grade and value-added products. The firm operates smelter facilities in the United States and Iceland. The majority of revenue is generated from Glencore, which agreed to purchase nearly all of Century Aluminum's North American production. The company produces high purity aluminum, standard-grade aluminum sow and tee bars, and value-added billet and foundry products. The company also owns a carbon anode production facility in the Netherlands.